David Klatzmann

David Klatzmann

Company: Sorbonne University, Pitié-Salpêtrière Hospital

Job title: Professor Of Immunology, Head of Biotherapy


Panel Discussion: Spearheading Acceleration of Next Generation Treg Therapies by Integrating Cell Based & Non Cell Based Approaches 4:30 pm

Highlighting the potential synergies and challenges with combining these two approaches and how this would positively impact future therapies Exploring successful examples of combination approaches to enhance current treatments Discussing regulatory considerations and approval pathways for combination therapies to address how this may impact therapeutic developmentRead more

day: Conference Day One

Navigating the Interplay of IL2 & Treg Cells for Therapeutic Success 2:30 pm

Introducing the pivotal role of IL2 in Treg functionality to explore the impact of IL2 based therapies Exploring means to provide IL-2 to Tregs to improve their survival, stability and functionality  Exploring the potential of providing Tregs with additional functions (e.g boosting IL-10)Read more

day: Day One PM Non-Cell Based Approaches

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.